Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277–300
   PubMed Web of Science ®Google Scholar
• Llovet JM, Ducreux M, Lencioni R, Di Bisceglie AM, Galle PR, Dufour JF, et al. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol 2012; 56: 908–943
   PubMed Web of Science ®Google Scholar
• Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology 2012; 262: 43–58
   PubMed Web of Science ®Google Scholar
• Chan SL, Yeo W. Targeted therapy of hepatocellular carcinoma: Present and future. J Gastroenterol Hepatol 2012; 27: 862–872
   PubMed Web of Science ®Google Scholar
• Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, et al. Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors. Cancer 2011; 117: 4475–4483
   PubMed Web of Science ®Google Scholar
• Davidson RS, Nwogu CE, Brentjens MJ, Anderson TM. The surgical management of pulmonary metastasis: Current concepts. Surg Oncol 2001; 10: 35–42
   PubMed Web of Science ®Google Scholar
• Nichols FC. Pulmonary metastasectomy. Thorac Surg Clin 2012; 22: 91–99
   PubMed Web of Science ®Google Scholar
• Pastorino U, Buyse M, Friedel G, Ginsberg R, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997; 113: 37–49
   PubMed Web of Science ®Google Scholar
• Pastorino U. History of the surgical management of pulmonary metastases and development of the International Registry. Semin Thorac Cardiovasc Surg 2002; 14: 18–28
   PubMedGoogle Scholar
• Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378–390
   PubMed Web of Science ®Google Scholar
• Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009; 10: 25–34
   PubMed Web of Science ®Google Scholar
• Yau T, Chan P, Ng KK, Chok SH, Cheung TT, Fan ST, et al. Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: Presence of lung metastasis predicts poor response. Cancer 2009; 115: 428–436
   PubMed Web of Science ®Google Scholar
• Kim HR, Cheon SH, Lee KH, Ahn JR, Jeung HC, Lee SS, et al. Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma. Int J Hyperthermia 2010; 26: 305–315
   PubMed Web of Science ®Google Scholar
• Pan C, Wu P, Yu J, Li W, Huang Z, He N, et al. CT-guided radiofrequency ablation prolonged metastatic survival in patients with liver metastases from nasopharyngeal carcinoma. Int J Hyperthermia 2011; 27: 549–554
   PubMed Web of Science ®Google Scholar
• Sung HH, Park BK, Kim CK, Choi HY, Lee HM. Comparison of percutaneous radiofrequency ablation and open partial nephrectomy for the treatment of size- and location-matched renal masses. Int J Hyperthermia 2012; 28: 227–234
   PubMed Web of Science ®Google Scholar
• Yamakado K, Inoue Y, Takao M, Takaki H, Nakatsuka A, Uraki J, et al. Long-term results of radiofrequency ablation in colorectal lung metastases: Single center experience. Oncol Rep 2009; 22: 885–891
   PubMed Web of Science ®Google Scholar
• Pan CC, Wu PH, Yu JR, Li W, Huang ZL, Wang JP, et al. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation. Eur J Radiol 2012; 81: e473–e477
   Web of Science ®Google Scholar
• Soga N, Yamakado K, Gohara H, Takaki H, Hiraki T, Yamada T, et al. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma. BJU Int 2009; 104: 790–794
   PubMed Web of Science ®Google Scholar
• Chua TC, Sarkar A, Saxena A, Glenn D, Zhao J, Morris DL. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: An open-labeled prospective trial of 148 patients. Ann Oncol 2010; 21: 2017–2022
   PubMed Web of Science ®Google Scholar
• Fernando HC, De Hoyos A, Landreneau RJ, Gilbert S, Gooding WE, Buenaventura PO, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129: 639–644
   PubMed Web of Science ®Google Scholar
• Younes RN, Fares AL, Gross JL. Pulmonary metastasectomy: A multivariate analysis of 440 patients undergoing complete resection. Interact Cardiovasc Thorac Surg 2012; 14: 156–161
   PubMed Web of Science ®Google Scholar
• Kitano K, Murayama T, Sakamoto M, Nagayama K, Ueno K, Murakawa T, et al. Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma. Eur J Cardiothorac Surg 2012; 41: 376–382
   PubMed Web of Science ®Google Scholar
• Gwak GY, Jung JO, Sung SW, Lee HS. Long-term survival after pulmonary metastatectomy of hepatocellular carcinoma: Treatment outcome or natural history?. Hepatogastroenterology 2004; 51: 1428–1433
   PubMedGoogle Scholar
• Kawamura M, Nakajima J, Matsuguma H, Horio H, Miyoshi S, Nakagawa K, et al. Surgical outcomes for pulmonary metastases from hepatocellular carcinoma. Eur J Cardiothorac Surg 2008; 34: 196–199
   PubMed Web of Science ®Google Scholar
• Kim TS, Lim HK, Lee KS, Yoon YC, Yi CA, Han D. Imaging-guided percutaneous radiofrequency ablation of pulmonary metastatic nodules caused by hepatocellular carcinoma: Preliminary experience. Am J Roentgenol 2003; 181: 491–494
   PubMed Web of Science ®Google Scholar
• Hiraki T, Yamakado K, Ikeda O, Matsuoka T, Kaminou T, Yamagami T, et al. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: Results of a multicenter study in Japan. J Vasc Interv Radiol 2011; 22: 741–748
   PubMed Web of Science ®Google Scholar
• Fernando HC. Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases. Ann Thorac Surg 2008; 85: S780–S784
   Web of Science ®Google Scholar
• Veltri A, Guarnieri T, Gazzera C, Busso M, Solitro F, Fora G, et al. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): Size as the leading prognostic factor for survival. Radiol Med 2012; 117: 1139–1151
   PubMed Web of Science ®Google Scholar
• Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12: 1175–1181
   PubMed Web of Science ®Google Scholar
• Dupuy DE. Image-guided thermal ablation of lung malignancies. Radiology 2011; 260: 633–655
   PubMed Web of Science ®Google Scholar
• Tada A, Hiraki T, Iguchi T, Gobara H, Mimura H, Toyooka S, et al. Influence of radiofrequency ablation of lung cancer on pulmonary function. Cardiovasc Intervent Radiol 2011; 35: 860–867
   PubMed Web of Science ®Google Scholar
• Demmy TL, Dunn KB. Surgical and nonsurgical therapy for lung metastasis: Indications and outcomes. Surg Oncol Clin N Am 2007; 16: 579–605
   PubMed Web of Science ®Google Scholar
• Jin Y, Cai YC, Cao Y, Cai XY, Tan YT, Shi YX, et al. Radiofrequency ablation combined with systemic chemotherapy in nasopharyngeal carcinoma liver metastases improves response to treatment and survival outcomes. J Surg Oncol 2012; 106: 322–326
   PubMed Web of Science ®Google Scholar
• Takao M, Yamakado K, Takeda K. Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer 2011; 117: 876–877
   PubMed Web of Science ®Google Scholar
• Kashima M, Yamakado K, Takaki H, Kodama H, Yamada T, Uraki J, et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: A single center's experiences. Am J Roentgenol 2011; 197: W576–W580
   PubMed Web of Science ®Google Scholar
• Rose SC, Dupuy DE, Gervais DA, Millward SF, Brown DB, Cardella JF, et al. Research reporting standards for percutaneous thermal ablation of lung neoplasms. J Vasc Interv Radiol 2009; 20: S474–S485
   Web of Science ®Google Scholar
• Purandare NC, Rangarajan V, Shah SA, Sharma AR, Kulkarni SS, Kulkarni AV, et al. Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings. Radiographics 2011; 31: 201–213
   PubMed Web of Science ®Google Scholar